Imaging of uterine leiomyomas

In: Uterine Fibroids · 2003 · pp. 16–30 · doi:10.1017/cbo9780511550218.005 · W1701579439
book-chapter OA: closed CC0
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-09

Imaging confirms uterine leiomyoma diagnosis, differentiates masses, assesses leiomyoma characteristics for treatment planning, recognizes complications, and monitors therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

This work reviews the role of imaging in diagnosing and characterizing uterine leiomyomas, emphasizing how imaging confirms the diagnosis and differentiates leiomyomas from other causes of uterine enlargement or pelvic masses, including adenomyosis and endometrial or ovarian-based masses. It highlights the need to assess the number, size, and location of leiomyomas, recognize complications such as benign degeneration, and evaluate for signs of malignant transformation, particularly in symptomatic, infertile, or pregnant patients. The paper also describes imaging as useful for preoperative mapping and for therapy monitoring in uterus-sparing contexts, while noting that the clinical relevance depends on accurate differentiation among competing diagnoses. Relevance to endometriosis: adenomyosis is explicitly listed as a differential diagnosis for uterine enlargement/pelvic masses, though the paper’s focus is imaging of uterine leiomyomas rather than endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The role of imaging is to confirm the diagnosis of uterine leiomyoma and to differentiate leiomyomas from other causes of uterine enlargement or pelvic masses such as ovarian or endometrial based masses, adenomyosis, serosal implants and lymphadenopathy. In addition, the number, size, and location of leiomyomas must be assessed. This is particularly important in the symptomatic, infertile, or pregnant patient. Possible complications including benign degeneration should be recognized. Signs suggestive of malignant transformation must be evaluated. Imaging is useful in preoperative mapping, particularly in the setting of uterus-sparing procedures and for therapy monitoring.
Full text 5,731 characters · extracted from oa-doi-fallback · click to expand
Uterine Fibroids Buy print or eBook [Opens in a new window] Embolization and other Treatments - Frontmatter - Contents - Contributors - Preface - Foreword - 1 Uterine fibroids: epidemiology and an overview - 2 Histopathology of uterine leiomyomas - 3 Imaging of uterine leiomyomas - 4 Abdominal myomectomy - 5 Laparoscopic managment of uterine myoma - 6 Hysteroscopic myomectomy - 7 Myomas in pregnancy - 8 Expectant and medical management of uterine fibroids - 9 Hysterectomy for uterine fibroid - 10 History of embolization of uterine myoma - 11 Uterine artery embolization – vascular anatomic considerations and procedure techniques - 12 Pain management during and after uterine artery embolization - 13 Patient selection, indications and contraindications - 14 Results of uterine artery embolization - 15 Side effects and complications of embolization - 16 Reproductive function after uterine artery embolization - 17 Reasons and prevention of embolization failure - 18 Future of embolization and other therapies from gynecologic perspectives - 19 The future of fibroid embolotherapy: a radiological perspective - Index - Plate section Published online by Cambridge University Press: 10 November 2010 Edited by Book contents - Frontmatter - Contents - Contributors - Preface - Foreword - 1 Uterine fibroids: epidemiology and an overview - 2 Histopathology of uterine leiomyomas - 3 Imaging of uterine leiomyomas - 4 Abdominal myomectomy - 5 Laparoscopic managment of uterine myoma - 6 Hysteroscopic myomectomy - 7 Myomas in pregnancy - 8 Expectant and medical management of uterine fibroids - 9 Hysterectomy for uterine fibroid - 10 History of embolization of uterine myoma - 11 Uterine artery embolization – vascular anatomic considerations and procedure techniques - 12 Pain management during and after uterine artery embolization - 13 Patient selection, indications and contraindications - 14 Results of uterine artery embolization - 15 Side effects and complications of embolization - 16 Reproductive function after uterine artery embolization - 17 Reasons and prevention of embolization failure - 18 Future of embolization and other therapies from gynecologic perspectives - 19 The future of fibroid embolotherapy: a radiological perspective - Index - Plate section Role of imaging The role of imaging is to confirm the diagnosis of uterine leiomyoma and to differentiate leiomyomas from other causes of uterine enlargement or pelvic masses such as ovarian or endometrial based masses, adenomyosis, serosal implants and lymphadenopathy. In addition, the number, size, and location of leiomyomas must be assessed. This is particularly important in the symptomatic, infertile, or pregnant patient. Possible complications including benign degeneration should be recognized. Signs suggestive of malignant transformation must be evaluated. Imaging is useful in preoperative mapping, particularly in the setting of uterus-sparing procedures and for therapy monitoring. General histology Uterine leiomyomas are well-circumscribed, benign smooth muscle neoplasms with various amounts of fibrous connective tissue. Leiomyomas may be single or, more frequently, multiple. Uterine leiomyomata are estrogen-sensitive neoplasms that occur in 20–30% of reproductive-aged women. Leiomyomas regress during anovulatory cycles as a result of unopposed estrogen stimulation. As leiomyomas enlarge, they may outgrow their blood supply, resulting in ischemia and degeneration characterized as hyaline, cystic, myxomatous, fatty, or hemorrhagic. Rapid increase in size of leiomyomas in a postmenopausal patient should raise the possibility of sarcomatous change. Classification by location Leiomyomas originate from the uterine corpus in the vast majority of cases; however, rarely (3–8%) they can arise from the cervical region. Uterine leiomyomas are categorized with respect to their location (subserosal, intramural, submucosal). - Type - Chapter - Information - Uterine FibroidsEmbolization and other Treatments, pp. 16 - 30Publisher: Cambridge University PressPrint publication year: 2003 Accessibility compliance for the PDF of this chapter is currently unknown and may be updated in the future. To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle. Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply. Find out more about the Kindle Personal Document Service. - Imaging of uterine leiomyomas - - Book: Uterine Fibroids - Online publication: 10 November 2010 To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox. - Imaging of uterine leiomyomas - - Book: Uterine Fibroids - Online publication: 10 November 2010 To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive. - Imaging of uterine leiomyomas - - Book: Uterine Fibroids - Online publication: 10 November 2010

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall
last seen: 2026-06-15T06:18:04.506796+00:00
License: CC0 · commercial use OK